期刊文献+

阴茎癌及其癌旁组织中癌基因ras产物P21蛋白的表达 被引量:1

Expression of Oncogene Ras Product P21 Protein in Carcinoma of Penis and its Surrounding
下载PDF
导出
摘要 目的探讨阴茎癌及其癌旁组织中癌基因ras产物P21蛋白表达的临床意义。方法用免疫组化ABC法检测32例阴茎癌、32例癌旁组织和16例正常阴茎组织的癌基因ras产物P21蛋白。结果28例癌组织,8例癌旁组织中有P21蛋白表达,而16例正常阴茎组织中P21阴性。P21蛋白和病理分级、临床分期呈正相关表达,即随分级和分期的上升阳性增强,并且癌旁组织P21蛋白表达阳性者显示早期复发和转移的不良预后。结论P21蛋白可作为阴茎癌的生物学指标。 Objective\ To explore the clinical significance of expression of oncogene ras product P21 protein in the tissues of penis cancer and its surrounding tissues.\ Methods\ Oncogen ras product P21 protein in 32 cases of penis cancer,32 cases of paracarcinoma tissues and in 16 cases of normal penis tissues were detected by immunohistochemical ABC method.\ Results\ It was showed that P21 protein expressed in 28 cases of penis cancer and 8 cases of paracarcinoma tissues,but they did not express in 16 cases of normal penis.\ Exprssion of P21 protein was related to the pathological grading and clinical stage.i.e.expression of P21 protein enhanced with the increasing of grading and stage.\ The positive cases of P21 protein expression in paracarcinoma tissue has worse impact on the prognosis of early recurrence and metastasis.\ Conclusion\ It was suggested that P21 protein could be used as tumor markers for penis cancer.
出处 《福建医科大学学报》 1997年第3期261-263,共3页 Journal of Fujian Medical University
基金 "九五"军队医药卫生科研基金
关键词 阴茎肿瘤 癌基因产物 P2蛋白 免疫组化 RAS基因 penis cancer oncogene P21 protein immunohistochemical
  • 相关文献

同被引文献15

  • 1何兆伟,陆灿辉,申鹏飞,罗欣鸣,黄世章.rasP21和P53在膀胱癌表达的临床意义[J].中华泌尿外科杂志,1996,17(1):20-23. 被引量:17
  • 2乔忠杰,赵丕显,陈辉,崔岩.术前应用平阳霉素化疗配合改良手术治疗阴茎癌疗效的初步观察[J].现代生物医学进展,2006,6(10):76-76. 被引量:2
  • 3李西启,姜元庆,邹积才,王剑波,盛文旭.Bcl-2 和 p53 基因蛋白在阴茎癌中的表达[J].实用癌症杂志,1997,12(2):115-116. 被引量:1
  • 4Sun D,Yu F. MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing Ras-p21 GTPase activating protein 1 (RASA1) [J]. Biol Chem,2013,288(13) :9508-9518.
  • 5Vioal MV, Fromowitz F, Oravez S, et al. Ras oneogene P21expression is increased in premalignant lesions and high grade bladder tumor [J]. J Exp Med, 1985,161 (5) : 1213- 1218.
  • 6Blumenschein GR Jr, Reck M. Plasma biomarkers correlat- ing with clinical outcome in a phase Ⅱ study of sorafenib in advanced NSCLC [J]. Cancer Biomark,2011-2012,10(6): 287-298.
  • 7Hu C,Huang F. miR-31 promotes oncogenesis in intrahep- atic cholangiocarcinoma cells via the direct suppression of RASA1 [J]. Exp Ther Med,2013,6(5) :1265-1270.
  • 8EL-Deriy WS,Tokino T,Velculescu VE,et al. WAFI,a po- tential of p53 tumor suppression [J]. Cell, 1993,75 (4) :817- 825.
  • 9Zhang W, Grasso L, Mcolain CD,et al. P53-independent in- duction of WAF1/CIP1 in human leukemia cells is correlat- ed with growth arrest accompanying monocyte/maceophage differentiation [J]. Cancer Res, 1995,55 (3) : 668-674.
  • 10Shaw P,Sklarj,Brada M,et al. Induction of apoptosis by Wild-type p53 in a human colon tumor derived cell line [J]. Proc Natl Acad Sci USA, 1992,89(10) :4495-4499.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部